导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.79% | 246/367 |
| 近一周 | 0.02% | 86/482 |
| 近一月 | -0.66% | 276/460 |
| 近一季 | 0.30% | 217/432 |
| 近半年 | 1.51% | 325/413 |
| 近一年 | 3.65% | 239/365 |
| 近两年 | 6.21% | 265/325 |
| 近三年 | 7.95% | 135/251 |
| 成立以来 | 30.43% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
1.31% 59/405 |
1.07% 234/439 |
1.14% 344/442 |
- - |
| 2024 | 2.15% 304/401 |
0.41% 199/376 |
0.68% 163/378 |
0.24% 312/391 |
0.80% 239/401 |
| 2023 | 1.86% 20/365 |
2.11% 30/310 |
-0.41% 143/328 |
-0.17% 43/345 |
0.34% 38/365 |
| 2022 | -6.25% 94/289 |
-4.49% 92/125 |
0.19% 123/163 |
-1.73% 81/197 |
-0.30% 37/289 |
| 2021 | 3.25% 52/121 |
-0.18% 395/633 |
2.44% 275/921 |
-0.69% 690/992 |
1.72% 31/121 |
| 2020 | 15.65% 15/64 |
-6.44% 325/336 |
10.17% 17/504 |
5.45% 163/587 |
6.41% 90/675 |
| 2019 | 11.26% 4/38 |
5.92% 2215/3053 |
0.53% 1110/3201 |
1.36% 226/359 |
3.10% 149/372 |
| 2018 | -3.18% 5/15 |
- - |
-0.84% 933/2983 |
0.81% 473/2970 |
-2.18% 875/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 宏利全能混合(FOF)A VS. () |